Trials / Withdrawn
WithdrawnNCT01283737
Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)
A Randomized, Subject-blind, Controlled Pilot Trial to Evaluate the Effectiveness and Safety of the Use of Demineralized Bone Matrix (DBX®) Versus Mosaicplasty in the Treatment of Late-Stage Osteochondritis Dissecans (OCD) of the Knee in Patients With a Mature Skeleton
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Synthes GmbH · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a 1:1 randomised pilot study in 30 patients in 1 site in Helsinki, Finland. The investigators hypothesize that function, pain, type and quality of cartilage in adult patients with osteochondritis dissecans of the knee will be better in the DBX group compared to the mosaicplasty group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DBX Putty | OCD of the knee will be treated with DBX Putty |
| PROCEDURE | Mosaicplasty | Mosaicplasty procedure performed to treat OCD of the knee |
Timeline
- First posted
- 2011-01-26
- Last updated
- 2012-06-26
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01283737. Inclusion in this directory is not an endorsement.